메뉴 건너뛰기




Volumn 7, Issue 4, 2006, Pages 155-162

A cohort study of the food effect on virological failure and treatment discontinuation in patients on HAART containing didanosine enteric-coated capsules (FOODDle study)

Author keywords

Adherence; Antiretroviral treatment; Didanosine; Virological failure

Indexed keywords

DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; STAVUDINE;

EID: 33750893346     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct0704-155     Document Type: Article
Times cited : (9)

References (19)
  • 2
    • 0034604276 scopus 로고    scopus 로고
    • Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
    • Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intem Med. 2000;133:21-30.
    • (2000) Ann Intem Med , vol.133 , pp. 21-30
    • Paterson, D.L.1    Swindells, S.2    Mohr, J.3
  • 3
    • 0034457843 scopus 로고    scopus 로고
    • Factors affecting adherence to antiretroviral therapy
    • Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(suppl 2):S171-176.
    • (2000) Clin Infect Dis , vol.30 , Issue.SUPPL. 2
    • Chesney, M.A.1
  • 4
    • 0035477744 scopus 로고    scopus 로고
    • Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: Survey of women in the her study
    • Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr. 2001;28:124-131.
    • (2001) J Acquir Immune Defic Syndr , vol.28 , pp. 124-131
    • Stone, V.E.1    Hogan, J.W.2    Schuman, P.3
  • 5
    • 0033370077 scopus 로고    scopus 로고
    • Didanosine: An updated review of its use in HIV infection
    • Perry CM, Noble S. Didanosine: an updated review of its use in HIV infection. Drugs. 1999;58:1099-1135.
    • (1999) Drugs , vol.58 , pp. 1099-1135
    • Perry, C.M.1    Noble, S.2
  • 6
    • 0035998756 scopus 로고    scopus 로고
    • Bioequivalence of two formulations of didanosine, encapsulated enteric-coated beads and buffered tablet, in healthy volunteers and HIV-infected subjects
    • Damle BD, Kaul S, Behr D, Knupp C. Bioequivalence of two formulations of didanosine, encapsulated enteric-coated beads and buffered tablet, in healthy volunteers and HIV-infected subjects. J Clin Pharmacol. 2002;42:791-797.
    • (2002) J Clin Pharmacol , vol.42 , pp. 791-797
    • Damle, B.D.1    Kaul, S.2    Behr, D.3    Knupp, C.4
  • 7
    • 85047697366 scopus 로고    scopus 로고
    • Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads
    • Damle BD, Yan JH, Behr D, et al. Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads. J Clin Pharmacol. 2002;42:419-427.
    • (2002) J Clin Pharmacol , vol.42 , pp. 419-427
    • Damle, B.D.1    Yan, J.H.2    Behr, D.3
  • 8
    • 19944428772 scopus 로고    scopus 로고
    • Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)
    • Iribarren JA, Labarga P, Rubio R, et al. [Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)]. Enferm Infecc Microbiol Clin. 2004;22:564-642.
    • (2004) Enferm Infecc Microbiol Clin , vol.22 , pp. 564-642
    • Iribarren, J.A.1    Labarga, P.2    Rubio, R.3
  • 9
    • 0036097706 scopus 로고    scopus 로고
    • Absence of clinically relevant drug interactions following simultaneous administration of didanosine-encapsulated, enteric-coated bead formulation with either itraconazole or fluconazole
    • Damle B, Hess H, Kaul S, Knupp C. Absence of clinically relevant drug interactions following simultaneous administration of didanosine-encapsulated, enteric-coated bead formulation with either itraconazole or fluconazole. Biopharm Drug Dispos. 2002;23:59-66.
    • (2002) Biopharm Drug Dispos , vol.23 , pp. 59-66
    • Damle, B.1    Hess, H.2    Kaul, S.3    Knupp, C.4
  • 10
    • 0036148655 scopus 로고    scopus 로고
    • Lack of effect of simultaneously administered didanosine encapsulated enteric bead formulation (Videx EC) on oral absorption of indinavir, ketoconazole, or ciprofloxacin
    • Damle BD, Mummaneni V, Kaul S, Knupp C. Lack of effect of simultaneously administered didanosine encapsulated enteric bead formulation (Videx EC) on oral absorption of indinavir, ketoconazole, or ciprofloxacin. Antimicrob Agents Chemother. 2002;46:385-391.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 385-391
    • Damle, B.D.1    Mummaneni, V.2    Kaul, S.3    Knupp, C.4
  • 13
    • 0026080378 scopus 로고
    • Decreased and variable systemic availability of zidovudine in patients with AIDS if administered with a meal
    • Lotterer E, Ruhnke M, Trautmann M, Beyer R, Bauer FE. Decreased and variable systemic availability of zidovudine in patients with AIDS if administered with a meal. Eur J Clin Pharmacol. 1991;40:305-308.
    • (1991) Eur J Clin Pharmacol , vol.40 , pp. 305-308
    • Lotterer, E.1    Ruhnke, M.2    Trautmann, M.3    Beyer, R.4    Bauer, F.E.5
  • 14
    • 0028848484 scopus 로고
    • The effect of food on pharmacokinetics of zalcitabine in HIV-positive patients
    • Nazareno LA, Holazo AA, Limjuco R, et al. The effect of food on pharmacokinetics of zalcitabine in HIV-positive patients. Pharm Res. 1995;12:1462-1465.
    • (1995) Pharm Res , vol.12 , pp. 1462-1465
    • Nazareno, L.A.1    Holazo, A.A.2    Limjuco, R.3
  • 15
    • 0027471409 scopus 로고
    • Anomalous accumulation and decay of 2′,3′-dideoxyadenosine-5′-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2′,3′-dideoxyinosine
    • Ahluwalia G, Cooney DA, Hartman NR, et al. Anomalous accumulation and decay of 2′,3′-dideoxyadenosine-5′-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2′,3′-dideoxyinosine. Drug Metab Dispos. 1993;21:369-376.
    • (1993) Drug Metab Dispos , vol.21 , pp. 369-376
    • Ahluwalia, G.1    Cooney, D.A.2    Hartman, N.R.3
  • 16
    • 0034689292 scopus 로고    scopus 로고
    • Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children
    • Pediatric AIDS Clinical Trials Group Protocol 144 Study Team
    • Stevens RC, Rodman JH, Yong FH, Carey V, Knupp CA, Frenkel LM. Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children. Pediatric AIDS Clinical Trials Group Protocol 144 Study Team. AIDS Res Hum Retroviruses. 2000;16:415-421.
    • (2000) AIDS Res Hum Retroviruses , vol.16 , pp. 415-421
    • Stevens, R.C.1    Rodman, J.H.2    Yong, F.H.3    Carey, V.4    Knupp, C.A.5    Frenkel, L.M.6
  • 17
    • 16844379887 scopus 로고    scopus 로고
    • Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunters
    • la Porte C, Verweij-van Wisen C, van Ewijk N, et al. Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunters. J Clin Pharmacol. 2005;45:211-218.
    • (2005) J Clin Pharmacol , vol.45 , pp. 211-218
    • la Porte, C.1    Verweij-van Wisen, C.2    van Ewijk, N.3
  • 18
    • 0033215016 scopus 로고    scopus 로고
    • Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients
    • The STADI Group
    • Reynes J, Denisi R, Massip P, Izopet J, Pellegrin I, Segondy M. Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients. The STADI Group. J Acquir Immune Defic Syndr. 1999;22:103-105.
    • (1999) J Acquir Immune Defic Syndr , vol.22 , pp. 103-105
    • Reynes, J.1    Denisi, R.2    Massip, P.3    Izopet, J.4    Pellegrin, I.5    Segondy, M.6
  • 19
    • 0035715574 scopus 로고    scopus 로고
    • Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz
    • Maggiolo F, Migilorino M, Maserati R, et al. Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz. Antivir Ther. 2001;6:249-253.
    • (2001) Antivir Ther , vol.6 , pp. 249-253
    • Maggiolo, F.1    Migilorino, M.2    Maserati, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.